Related Experiment Videos
The Nathalie syndrome. A new hereditary syndrome
Clinical Genetics
|November 1, 1975
Abstract:
Deafness, cataract, muscular atrophy, skeletal abnormalities, retardation of growth, underdeveloped secondary sexual characteristics, and electrocardiographic abnormalities are the features of a new, probably hereditary syndrome. Case reports are presented.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[From gene to disease; non-syndromic, autosomal dominant, low-frequency sensorineural hearing loss (DFNA6/14)].
Nederlands tijdschrift voor geneeskunde·2003
Velo-cardio-facial syndrome: guidelines for diagnosis, treatment and follow-up of ent manifestations.
Acta oto-rhino-laryngologica Belgica·2003
Hereditary cochleovestibular dysfunction due to a COCH gene mutation (DFNA9): a follow-up study of a family.
Clinical otolaryngology and allied sciences·2002
Vibrant semi-implantable hearing device with digital sound processing: effective gain and speech perception.
Archives of otolaryngology--head & neck surgery·2001
Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss.
Human molecular genetics·2001
Fluctuant, progressive hearing loss associated with Menière like vertigo in three patients with the Pendred syndrome.
International journal of pediatric otorhinolaryngology·2001
Allele-specific expression modulates the immunological and cis-regulatory landscape of Parkinson's Disease.
Computers in biology and medicine·2026
Distinct genotype-phenotype patterns in non-syndromic hereditary hypotrichosis: a multicenter Chinese cohort.
The British journal of dermatology·2026
Beyond in silico prediction: multi-omics to identify a pathogenic deep intronic HNRNPK variant in Au-Kline syndrome.
Journal of human genetics·2026
Phenotypes of Hereditary Diseases Associated With Rauch-Steindl Syndrome.
Human mutation·2026
Multi-omics Mendelian Randomization Prioritizes Neutrophil Extracellular Trap-related Genes Associated with Atrial Fibrillation Risk.
Endocrine, metabolic & immune disorders drug targets·2026
Developmental and cellular vulnerabilities underlie genetic architecture of schizophrenia.
Molecular psychiatry·2026